#charlesschwab#spcx
Set a stoploss that is frozen and cant sell my shares!!!
We are seeing a street wide issue right now with orders. Our technology teams and order room is working to investigate and resolve as quickly as we can.
@GovofCO My hope for Colorado's future comeback (not the avalanche, the state) is reading the comments on every one of your posts. No one supports you, even your own party!
@brwtoovey@DrSamuelBHume I think with positive data after this readout a SLN acquisition will be announced within weeks not months. The buyer is probably already lined up.
@usasingh1 This article seems like Ai slop. Once the pelacarsen trial results come out a buyer will be lined up to grab their stage 3 ready cholesterol med imo.
@Ashwinreads Waiting for enough heart related incidents to occur (the study measures how many cardiovascular events in the placebo and drug group) lead doctor said they expect study to finalize before end of July.
@Vanhengeltim The 1st Catalyst for this will be the Perlacarsen trials due H12026 from Ionis/Novartis phase 3 trial. If that shows reduced cardiac events then its game on for a Silence Buyout. The stock will gap on those results and smart money will hold for the acquisition to follow
$SLN trading up 9% on Double its typical volume today with no news. $AZN buyout still on the table ahead of their Q4 earnings and NYSE Listing. Maybe to coincide with the RNA Conference Next Week..
@awisejester Lots of deals still close a few weeks post JPM. Maybe a chance before the Q4 Earnings for AZN on Feb 10th. I'm not worried about today, low volume retail sellers. Market Closed Monday, I'll probably buy more shares Tuesday if it looks like the shakeout is finished.
@awisejester The event tag is gone from silence but the pages for the sale still exist. Maybe waiting till the AZN team is back in London? Maybe waiting for their shift to NYSE?
@awisejester I've had my gemini working overtime looking into different angles about this. If we are right this is the best kept secret in m&a for the jpm ever.